Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 May 2007, Vol. 109, No. 9, pp. 3616.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tschoep, K. E.
Right arrow Articles by Noessner, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tschoep, K. E.
Right arrow Articles by Noessner, E.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

IMMUNOBIOLOGY

Comment on Bros et al, page 3820

Understand tolerogenic dendritic cells

Katharina E. Tschoep, and Elfriede Noessner

UNIVERSITY OF MUNICH MEDICAL CLINIC AND GSF

In this issue of Blood, Bros and colleagues report thoroughly how glucocorticoid (GC) treatment of a murine dendritic cell (DC) line during maturation induces a stable dendritic cell state with tolerogenic characteristics, similar to that described with GC-treated bone marrow–derived dendritic cells.

Although the morphology of glucocorticoid (GC)–treated dendritic cells (DCs) is similar to conventionally matured DCs, they exert poor allogeneic and syngeneic T-cell stimulatory capacity and induce anergic T cells with inhibitory function. Of interest, despite the suppressed expression of costimulatory molecules in GC-treated DCs, the mRNA levels were comparable with conventionally matured DCs. So far, several studies showed impaired maturation, migration, and T-cell stimulatory capacity of GC-treated murine DC lines1,2 and human myeloid DCs.3,4 In contrast to these previous studies, Bros and colleagues extensively characterized the immunologic phenotypes, of their stable and tolerogenic DC line. Particularly, 2 aspects are of interest in this paper: first, the GCs that are used to induce tolerogenicity and second, the state of tolerogenicity itself. Concerning the first aspect, GCs (cortisol in humans) are widely applied as immunosuppressive and anti-inflammatory agents to treat autoimmune or allergic disease and to prevent graft rejection. They play a crucial role in inducing tolerance to environmental and self-antigens and undermine primary and memory CD8+ cytotoxic T-lymphocyte responses. Besides, GCs are also commonly used in the treatment of B-cell malignancies based on their potential to directly induce apoptosis. Concerning the second aspect, the properties of a tolerogenic state are not understood in detail and are certainly complex. An abundantly available cell line with stable characteristics is a valuable tool to more deeply investigate the GCs and the tolerogenic state in general on dendritic cells. It paves the way to perform detailed studies on the diverse functional aspects of tolerogenicity, including antigen presentation, migratory function, cytokine secretion, and costimulatory capacity. This knowledge will provide a rationale for intervention, for example conserving one DC function while suppressing another, such as preserving antitumor effects of GCs against B-cell malignancies, while inhibiting the negative impact on antigen presentation and T-cell stimulatory capacity of DCs.

Physiologically GCs are hormones that are naturally released via the hypothalamic-pituitary-adrenal axis in response to certain stimuli, such as stress. Therefore, their regulatory function extends beyond the clinical setting to daily life.

Footnotes

Conflict-of-interest disclosure: The authors declare no competing financial interests. {blacksquare}

REFERENCES

  1. Vizzardelli C, Pavelka N, Luchini A, et al. Effects of dexamethazone on LPS-induced activation and migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis. Eur J Immunol 2006; 36:1504–1515.[CrossRef][Medline] [Order article via Infotrieve]

  2. Quah B, Ni K, O'Neill HC. In vitro hematopoiesis produces a distinct class of immature dendritic cells from spleen progenitors with limited T cell stimulation capacity. Int Immunol 2004; 16:567–577.[Abstract/Free Full Text]

  3. Matsue H, Yang C, Matsue K, Edelbaum D, Mummert M, Takashima A. Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation. J Immunol 2002; 169:3555–3564.[Abstract/Free Full Text]

  4. Piemonti L, Monti P, Allavena P, et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999; 162:6473–6481.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid
Matthias Bros, Frank Jährling, Andrea Renzing, Nadine Wiechmann, Ngoc-Anh Dang, Arne Sutter, Ralf Ross, Jürgen Knop, Stephan Sudowe, and Angelika B. Reske-Kunz
Blood 2007 109: 3820-3829. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tschoep, K. E.
Right arrow Articles by Noessner, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tschoep, K. E.
Right arrow Articles by Noessner, E.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020